2022
DOI: 10.1002/ejic.202100949
|View full text |Cite
|
Sign up to set email alerts
|

Design, Synthesis and Biological Evaluation of Boron‐Containing Macrocyclic Polyamine Dimers and Their Zinc(II) Complexes for Boron Neutron Capture Therapy

Abstract: Boron neutron capture therapy (BNCT) is considered to have potential for cancer therapy based on the nuclear reaction between boron ( 10 B) atoms and thermal neutrons, yielding 4 He 2 + (α) and 7 Li 3 + ions. These heavy particles induce the destruction of biomolecules within short path length of 5-9 μm, resulting in a limited cytotoxic effect to 10 B-containing cells. Herein, we report on the design and synthesis of DNA-targeting BNCT agents equipped with homo-and hetero-dimeric macrocyclic polyamine units an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 146 publications
0
1
0
Order By: Relevance
“…The synthesis of reactive 10 B derivatives plays a crucial role in boron neutron capture therapy, as it enables the nuclear reactions between 10 B-containing molecules and thermal neutrons, resulting in the release of α particles and lithium atoms that effectively eradicate tumour cells. In this context, Ueda et al [129] successfully designed and synthesized borate-modified [9]aneN 3 , [12]aneN 4 and [15]aneN 5 derivatives by linking the borate ester and polyamine through a benzene ring. Their studies demonstrate the high selectivity of single or dual-protonated [12]aneN 4 -and [15]aneN 5 -10 B derivatives for uptake by A549 cells, where they effectively induce cell death through reaction with thermal neutrons upon interaction with zinc ions.…”
Section: Diagnostic and Therapeutic Reagentsmentioning
confidence: 99%
See 1 more Smart Citation
“…The synthesis of reactive 10 B derivatives plays a crucial role in boron neutron capture therapy, as it enables the nuclear reactions between 10 B-containing molecules and thermal neutrons, resulting in the release of α particles and lithium atoms that effectively eradicate tumour cells. In this context, Ueda et al [129] successfully designed and synthesized borate-modified [9]aneN 3 , [12]aneN 4 and [15]aneN 5 derivatives by linking the borate ester and polyamine through a benzene ring. Their studies demonstrate the high selectivity of single or dual-protonated [12]aneN 4 -and [15]aneN 5 -10 B derivatives for uptake by A549 cells, where they effectively induce cell death through reaction with thermal neutrons upon interaction with zinc ions.…”
Section: Diagnostic and Therapeutic Reagentsmentioning
confidence: 99%
“…In this context, Ueda et al . [ 129 ] successfully designed and synthesized borate-modified [9]aneN 3 , [12]aneN 4 and [15]aneN 5 derivatives by linking the borate ester and polyamine through a benzene ring. Their studies demonstrate the high selectivity of single or dual-protonated [12]aneN 4 - and [15]aneN 5 - 10 B derivatives for uptake by A549 cells, where they effectively induce cell death through reaction with thermal neutrons upon interaction with zinc ions.…”
Section: Applications Of Macrocyclic Polyaminesmentioning
confidence: 99%
“…In this context, we designed and synthesized some novel DNA-targeting BNCT agents containing macrocyclic polyamine scaffolds such as [9]aneN 3 , [12]aneN 4 , and [15] aneN 5 and their Zn 2+ complexes, which contain phenylboronic acid units, as shown in Figures 17 and 18 [55,56]. It was assumed that these boron-containing macrocyclic polyamine monomers 44-49 (L 6 -L 12 ) and their Zn 2+ complexes 50-52 (ZnL 6 -ZnL 12 ) would be efficiently transferred into cancer cells and that thermal neutron irradiation would induce effective DNA damage in cancer cells due the 10 B atoms being located in close proximity to DNA molecules (Figure 17).…”
Section: Design and Synthesis Of Boron-containing Macrocyclic Polyami...mentioning
confidence: 99%